|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A mul-tilevel model of group social capital显示文摘 | Hongseok Oh Giuseppe Labianca Myung-ho Chung | 2006 | Academy of Management re-view2006，31，3： | 1 |
| 2 | Activity and safety of pegylated liposomal doxorubicin,5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma:A phase Ⅱ study显示文摘AIM: To improve the results of New therapeutic strategies in hepatocellular carcinoma (HCC). We have conducted a phase Ⅱ study with pegylated liposomal doxorubicin (PLD), 5-fluorouracil (5FU) and folinic acid (FA). METHODS: Thirty-one patients with hystologically- confirmed, inoperable HCC, received combination chemotherapy with PLD 25 mg/mq on d 1, 5FU 1200 mg/mq in 48 h continuous infusion, and oral FA 30 mg on d 1 and 2 every 3 wk until disease progression or intolerable toxicity. RESULTS: The median age was 65 years (range 41-82) and 28 patients were hepatitis C virus seropositive (90%). The majority of patients were Child-Pugh Class B (55%). Two patients showed a partial response (PR), and 16 had stable disease (SD). With a median follow-up of 14 mo, the median time to progression of all evaluable patients was 4 mo (95% CI 1.7-7). Median overall survival was 9 mo (95% CI 3-24 mo). After 1 year, 9 of 18 PR/SD patients were alive. Chemotherapy was well tolerated. CONCLUSION: PLD/FU/FA combination seems capable of achieving durable stabilization of HCC. The manageable toxicity supports a role for combination with other anticancer agents. | Giuseppe Di Lorenzo Antonio Rea Chiara Carlomagno Stefano Pepe Giovannella Palmieri Roberto Labianca Antonio Chirianni Alfonso De Stefano Vincenzo Esposito Sabino De Placido Vincenzo Montesarchio | 2007 | World Journal of Gastroenterology2007，13，48： | 1 |
| 3 | A mul-tilevel model of group social capital 显示文摘 | Hongseok Oh Giuseppe Labianca Myung-ho Chung | 2006 | The Academy ofManagement Journal2006，，： | 1 |
| 4 | A Grounded Model of Organizational Schema Change During Empowerment显示文摘 | Giuseppe Labianca Barbara Gray Daniel J. Brass | 2000 | Organization Science2000，，2： | 1 |
| 5 | Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial显示文摘 | Stefano Cascinu Rossana Berardi Roberto Labianca Salvatore Siena Alfredo Falcone Enrico Aitini Sandro Barni Francesco Di Costanzo Elisa Dapretto Giuseppe Tonini Chiara Pierantoni Salvatore Artale Silvia Rota Irene Floriani Mario Scartozzi Alberto Zaniboni | 2008 | Lancet Oncology2008，，1： | 1 |
| 6 | FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study显示文摘 | Alberto Zaniboni Enrico Aitini Sandro Barni Daris Ferrari Stefano Cascinu Vincenzo Catalano Giuseppe Valmadre Domenica Ferrara Enzo Veltri Claudio Codignola Roberto Labianca | 2012 | Cancer Chemotherapy and Pharmacology2012，，6： | 1 |
| 7 | Group So cial Capital and Group Effectiveness:the Role of Informal Social izing Ties显示文摘 | Oh Hongseok Chung Myung-Ho Labianca Giuseppe | 2004 | Academy of Management Journal2004，47，6： | 1 |
| 8 | A Multilevel Model of Group Social Capital显示文摘 | Oh Hongseok Labianca Giuseppe | 2006 | Academy of Management Review2006，31，3： | 1 |
| 9 | Understanding Decisions to Internationalize by Small and Medium-sized Firms Located in an Emerging Market显示文摘 | Ass. Prof. Frances Fabian Prof. Henry Molina Assoc. Prof. Giuseppe Labianca | 2009 | Management International Review2009，，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员